Influence of an Immunodominant Herpes Simplex Virus Type 1 CD8+ T Cell Epitope on the Target Hierarchy and Function of Subdominant CD8+ T Cells
Overview
Authors
Affiliations
Herpes simplex virus type 1 (HSV-1) latency in sensory ganglia such as trigeminal ganglia (TG) is associated with a persistent immune infiltrate that includes effector memory CD8+ T cells that can influence HSV-1 reactivation. In C57BL/6 mice, HSV-1 induces a highly skewed CD8+ T cell repertoire, in which half of CD8+ T cells (gB-CD8s) recognize a single epitope on glycoprotein B (gB498-505), while the remainder (non-gB-CD8s) recognize, in varying proportions, 19 subdominant epitopes on 12 viral proteins. The gB-CD8s remain functional in TG throughout latency, while non-gB-CD8s exhibit varying degrees of functional compromise. To understand how dominance hierarchies relate to CD8+ T cell function during latency, we characterized the TG-associated CD8+ T cells following corneal infection with a recombinant HSV-1 lacking the immunodominant gB498-505 epitope (S1L). S1L induced a numerically equivalent CD8+ T cell infiltrate in the TG that was HSV-specific, but lacked specificity for gB498-505. Instead, there was a general increase of non-gB-CD8s with specific subdominant epitopes arising to codominance. In a latent S1L infection, non-gB-CD8s in the TG showed a hierarchy targeting different epitopes at latency compared to at acute times, and these cells retained an increased functionality at latency. In a latent S1L infection, these non-gB-CD8s also display an equivalent ability to block HSV reactivation in ex vivo ganglionic cultures compared to TG infected with wild type HSV-1. These data indicate that loss of the immunodominant gB498-505 epitope alters the dominance hierarchy and reduces functional compromise of CD8+ T cells specific for subdominant HSV-1 epitopes during viral latency.
Pseudorabies Virus Glycoproteins E and B Application in Vaccine and Diagnosis Kit Development.
Bude S, Lu Z, Zhao Z, Zhang Q Vaccines (Basel). 2024; 12(9).
PMID: 39340108 PMC: 11435482. DOI: 10.3390/vaccines12091078.
The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.
Antony F, Kinha D, Nowinska A, Rouse B, Suryawanshi A Clin Microbiol Rev. 2024; 37(3):e0000624.
PMID: 39078136 PMC: 11391706. DOI: 10.1128/cmr.00006-24.
Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines.
Uche I, Stanfield B, Rudd J, Kousoulas K, Rider P Front Mol Biosci. 2022; 9:832393.
PMID: 35155582 PMC: 8826227. DOI: 10.3389/fmolb.2022.832393.
Hilario G, Sulczewski F, Liszbinski R, Mello L, Hagen G, Fazolo T IET Nanobiotechnol. 2021; 15(6):532-544.
PMID: 34694744 PMC: 8675790. DOI: 10.1049/nbt2.12043.
Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.
St Leger A, Koelle D, Kinchington P, Verjans G Front Immunol. 2021; 12:723809.
PMID: 34603296 PMC: 8479180. DOI: 10.3389/fimmu.2021.723809.